Timothy Anderson is a Thoracic Surgeon in Norwood, Massachusetts. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Gastrostomy, and Advanced Bronchoscopy.

Andris Zauls is a Radiation Oncologist in Brockton, Massachusetts. Dr. Zauls is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer. Dr. Zauls is currently accepting new patients.

Robert Faberman is a Radiologist in Norwood, Massachusetts. Dr. Faberman is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Galactocoele, Visceromegaly, Ascites, and Breast Lump.

Dr. Steven J. Mentzer is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is a professor of surgery at Harvard Medical School.Dr. Mentzer received his medical degree from the University of Minnesota and received his general surgical residency training at the Brigham. He completed a cardiothoracic surgery fellowship at the University of Toronto. Dr. Mentzer also completed a research fellowship at Dana-Farber Cancer Institute where he investigated the molecular mechanisms involved in the regulation of T lymphocyte function. He is board certified in surgery, cardiothoracic surgery, and surgical critical care.Dr. Mentzer’s clinical interests include diseases of the lungs and thoracic cancers, minimally invasive surgery of the lungs and esophagus, and minimally invasive surgery for esophageal cancer. Principal investigator for The Mentzer Lab, Dr. Mentzer is currently studying the adaptive processes involved in blood vessel growth (angiogenesis) and lung regeneration. Dr. Mentzer is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Gastrostomy, and Endoscopy.

Dr. Jon Wee is the Esophageal Surgery Section Chief, Director of Robotics in Thoracic Surgery, and co-Director of Minimally Invasive Thoracic Surgery at Brigham and Women’s Hospital. He is also an Associate Program Director for Thoracic Surgery and is an Assistant Professor of Surgery at Harvard Medical School.Dr. Wee received his medical degree from the Duke University School of Medicine and completed his surgical training at Brigham and Women’s Hospital. He then went on to complete his cardiothoracic surgery training at the University of Pittsburgh Medical Center. He is board certified in surgery and thoracic surgery.Dr. Wee’s clinical interest is in minimally invasive approaches to thoracic diseases. These include minimally invasive and robotic esophagectomy, lobectomy, thymectomy and mediastinal resection for thoracic malignancies.  In addition, he treats benign esophageal disease such as gastro-esophageal reflux disease, giant paraesophageal hernias, diverticulum, etc. He performs POEM procedures for achalasia as well as sympathectomy for hyperhidrosis and endoluminal therapies such as PDT, laser, and stents for palliation. His research interest is in the use of minimally invasive techniques to decrease pain, improve recovery, and improve ultimate outcomes. Dr. Wee is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Endoscopy, and Thymectomy.

Dr. Ciaran McNamee is a thoracic surgeon at Brigham and Women’s Hospital and Dana-Farber Brigham Cancer Center. He is chief of thoracic surgery at Kent Hospital and is an instructor in surgery at Harvard Medical School. Dr. McNamee received his medical degree from McGill University in Canada and completed a surgery residency at University of Alberta Hospital as well as cardiothoracic surgery residencies at Broadgreen Hospital and Royal Devon and Exeter Hospital. He completed a clinical fellowship in thoracic surgery at the University of Manitoba and a research fellowship in thoracic surgery at the University of Alberta. Board certified in surgery and thoracic surgery, Dr. McNamee holds a Fellowship of the Royal College of Surgeons (FRCS). Dr. McNamee's clinical interests include lung cancer, lung cancer screening and esophageal cancer. His research focuses on mutational changes in lung cancer, regional outcome analysis and telemedicine. Dr. McNamee has been listed as one of America’s Top Doctors by Castle Connolly. Dr. Mcnamee is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Gastrostomy, and Advanced Bronchoscopy.

Dr. Wain joined the Brigham in February 2023 as a Surgeon, and Associate Chief of Quality and Safety, both for the Thoracic Surgery Department. Before joining the Brigham, Dr. Wain was the chief of the Division of Thoracic Surgery and the vice chairman of the Department of Surgery at St. Elizabeth’s Medical Center He’s a member of various societies, including the American Thoracic Society, the American College of Chest Physicians, the Society of Thoracic Surgeons and the American Association for Thoracic Surgery. Dr. Wain received his undergraduate degree from Pennsylvania State University and his medical degree from Jefferson Medical College. He completed residency training in surgery at Massachusetts General Hospital. After a surgical research fellowship at the City of Hope National Medical Center, he completed a fellowship in cardiothoracic surgery at Massachusetts General Hospital and Toronto General Hospital. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Wain is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Endoscopy, and Osteotomy.

Dr. Daniel C. Daniel Wiener is a thoracic surgeon at Brigham and Women's Hospital and an Assistant Professor of Surgery at Harvard Medical School. After graduating with honors from Columbia University, College of Physicians and Surgeons, he completed his surgical training at Dartmouth Hitchcock Medical Center. With additional training as research fellow in tumor immunology at the Dana Farber Cancer Institute, he then pursued his interest in thoracic surgery as a resident at Brigham and Women's Hospital. He is board certified in general surgery and thoracic surgery. Dr. Wiener is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Hiatal Hernia, Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Endoscopy, and Thymectomy.

Dr. Hisashi Tsukada is a thoracic surgeon at Brigham and Women’s Hospital.  He is also an assistant professor in surgery at Harvard Medical School. He received his medical degree and a PhD in medicine from St. Marianna University School of Medicine (Kawasaki, Japan). He then completed a residency in surgery at Mitsui Memorial Hospital (Tokyo). His fellowships include thoracic surgery at St. Marianna University Hospital, thoracic surgery research at Beth Israel Deaconess Medical Center and interventional pulmonology at St. Elizabeth’s Medical Center.   Dr. Tsukada specializes in Interventional Pulmonology and his clinical interests concentrate on aligning his research investigations to disease processes he has observed in patients as a practicing thoracic surgeon for more than ten years in Japan. Dr. Tsukada started his service at Brigham and Women’s Hospital in October 2014. He has expanded the Interventional Pulmonology procedures up to 1,000 cases per year in 2023. Dr. Tsukada is research focuses on developing an artificial trachea for in vivo implantation and airway tissue regeneration. He has authored 30 peer-reviewed publications. Dr. Tsukada is fluent in Japanese. Dr. Tsukada is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Lymphofollicular Hyperplasia, Mesothelioma, Advanced Bronchoscopy, and Endoscopy.

Katherine Krajewski is a Radiologist in Boston, Massachusetts. Dr. Krajewski is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Renal Cell Carcinoma (RCC), ALK-Positive Non-Small Cell Lung Cancer, Cholangiocarcinoma (Bile Duct Cancer), and WT1-Related Wilms Tumor Syndromes.

David Kozono is a Radiation Oncologist in Boston, Massachusetts. Dr. Kozono is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.

Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.

Sidharta Gangadharan is a Thoracic Surgeon in Boston, Massachusetts. Dr. Gangadharan is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Tracheobronchomalacia, Acquired Tracheomalacia, Lung Nodules, Endoscopy, and Gastrectomy.

Theodore Hong is a Radiologist in Needham, Massachusetts. Dr. Hong is rated as an Advanced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy.

Kelly Downey is an Internal Medicine provider in Needham, Massachusetts. Dr. Downey is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Familial Pancreatic Cancer, Paget Disease of the Breast, Pancreatic Ductal Adenocarcinoma, and Inflammatory Breast Cancer.

Jill Reinherz is a Radiologist in Needham, Massachusetts. Dr. Reinherz is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Chronic Cough, Vertigo, Mikulicz Disease, and Breast Lump.

Karen Scanlan is an Internal Medicine provider in Needham, Massachusetts. Dr. Scanlan is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, X-Linked Retinitis Pigmentosa (XLRP), and Lynch Syndrome.

Mark Lipsky is a Radiologist in Milton, Massachusetts. Dr. Lipsky is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Knock Knees, Gallbladder Disease, Rhizarthrosis, and Tenosynovitis.

Phoebe Olhava is a Radiologist in Milton, Massachusetts. Dr. Olhava is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Pleurisy, Pleural Effusion, Breast Lump, and Emphysema.